# Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck Cancer

> **NCT00273546** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 500 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** XRP6976 (Docetaxel/Taxotere)

## Key facts

- **NCT ID:** NCT00273546
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-05
- **Primary completion:** 2006-02
- **Final completion:** 2006-02
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2009-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00273546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00273546, "Induction Chemotherapy Comparing Taxotere® Cisplatin and 5-Fluorouracil (TPF) With Standard Cisplatin and 5-Fluorouracil (PF) Followed by Chemoradiation in Locally Advanced Head and Neck Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00273546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*